China NMPA Inspection - Harbin Sanlian Pharmaceutical Co., Ltd. - July 03, 2018
China NMPA unannounced inspection for Harbin Sanlian Pharmaceutical Co., Ltd. published July 03, 2018. An inspection conducted by the State Food and Drug Administration's Verification Center, as part of a drug tracking plan, revealed significant non-com
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA unannounced inspection for Harbin Sanlian Pharmaceutical Co., Ltd. published July 03, 2018. An inspection conducted by the State Food and Drug Administration's Verification Center, as part of a drug tracking plan, revealed significant non-com
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
Unknown Date
Product Type
Drugs
ID: c38be4f2-34b5-4261-94c1-3fe3782f323f
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox